When her microbiome’s natural balance is disturbed, a woman can have health challenges which impact her life quality and can be uncomfortable to talk about.
A balanced microbiome is key to maintaining a woman’s health, as it promotes health and mental well-being.
You can enable every woman to nurture and care for her nature by offering natural, clinically documented biotics to support health throughout life.
If a microbiome isn’t in balance, too many unwanted bacteria and/or yeast can grow. That can lead to several health challenges. Here are the most common ones.
50-60% of women experience urinary tract discomfort in their lifetime, and 20-30% of these women experience it more than once.1
50% of women experience vaginal bacterial imbalance2 and 75% will experience yeast growth3. Both can be unpleasant with vaginal itching, discharge and odor4.
Almost 1/3 of all women experience regular digestive discomfort4. For example, regularity can be an issue in connection with menstrual cycles5.
Women are 30 times more likely to develop urinary tract discomfort than men. Many are searching for a natural way to avoid these episodes5,6.
Of people who take probiotics, take them to aid the digestive system1.
The world’s most documented probiotic for women’s urogenital health, Urex™, is a combination of Lactobacilli rhamnosus, GR-1® and Lactobacilli reuteri, RC-14™.
It supports a healthy microbiota in the vagina and urinary tract, and may provide relief from occasional discomfort7-13.
Female digestive health: Astarte™ + BB-12®
Female immune support: Urex™ + L.CASEI 431®
Urogenital health: Urex™
Vaginal yeast overgrowth: LA-5®
Vaginal health: Astarte™
And you can make your offering even more targeted by optimizing it to benefit a specific life stage.
Reach out to talk about tailoring your own, unique solution.
How are you capitalizing on trends for more CFUs?
Whatever it is, let us know. Together, we can help people with their gastrointestinal discomfort. It’s a question of better health.
To complete the get in touch form or sign up, please click on the button below to enable cookies.
This content is intended exclusively for business-to-business purposes for a professional audience only and is not intended to target consumers.
1. Boeri et al. Six Out of Ten Women with Recurrent Urinary Tract Infections Complain of Distressful Sexual Dysfunction - A Case-Control Study. Sci Rep. 2017 Mar 15;7:44380.
2 Bradshaw et al, PLoS ONE, 2013; 8(3) | 6 Allsworth & Peipert, Obstetrics and gynecology, 2007; 109(1):114-20 | 7 Chico et al, JAMA, 2012; 307(19):2079–2086
3 Anh et al. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam. BMC Infect Dis. 2021 Jun 3;21(1):523.
4 Avramidou et al., Epidemiology of gastrointestinal symptoms in young and middle-aged Swiss adults: prevalences and comorbidities in a longitudinal population cohort over 28 years. BMC Gastroenterol. 2018 Jan 27;18(1):21.
5 Turnbull et al. Relationships between symptoms, menstrual cycle and orocaecal transit in normal and constipated women. Gut. 1989 Jan;30(1):30-4.
6 Tan CW, Chlebicki MP. Urinary tract infections in adults. Singapore Med J. 2016 Sep;57(9):485-90.
7 Scott et al., Fear and Frustration among Women with Recurrent Urinary Tract Infections: Findings from Patient Focus Groups. J Urol. 2021 Sep;206(3):688-695.
8 Petricevic et al.,Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2008 Nov;141(1):54-7.
9 Anukam et al., Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect. 2006 Oct;8(12-13):2772-6.
3 Martinez et al., Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can J Microbiol. 2009 Feb;55(2):133-8.
10 Vujic et al., Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blind, randomized, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 2013 May;168(1):75-9.
11 Reid et al., Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003 Mar 20;35(2):131-4.
12 Reid et al., Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli. J Med Food. 2004 Summer;7(2):223-8.
13 Beerepoot et al., Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012 May 14;172(9):704-12.